Previous studies indicate that the serum level of FGA is upregulated in many tumors, such as gastric cancer, breast cancer, nasopharyngeal carcinoma, acute lymphocytic leukemia, esophageal squamous cell carcinoma, and renal cell cancer (31–35). The gene discussed is FGA; the disease is renal cell adenocarcinoma.